05/29/2026 | Press release | Distributed by Public on 05/29/2026 15:10
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 22, 2026, at the 2026 Annual Meeting of stockholders (the "Annual Meeting") of Immix Biopharma, Inc. (the "Company"), the Company's stockholders voted on the following two (2) proposals and votes were cast as described below. These matters are described in more detail in the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on April 6, 2026.
The final results of voting on each proposal presented at the Annual Meeting are set forth below.
| 1. |
Proposal 1 - Election of Directors Proposal The stockholders elected each of the individuals listed below to serve as a director of the Company until the next annual meeting of stockholders and until such director's successor is duly elected and qualified. The results of the voting for this proposal were as follows: |
| For | Withheld | Broker Non-Votes | ||||||||||
| Ilya Rachman | 35,738,887 | 121,893 | 6,445,684 | |||||||||
| Gabriel Morris | 34,353,302 | 1,507,479 | 6,445,683 | |||||||||
| Jason Hsu | 35,844,812 | 15,969 | 6,445,683 | |||||||||
| Magda Marquet | 35,731,188 | 129,592 | 6,445,684 | |||||||||
| Helen C. Adams | 35,677,258 | 183,522 | 6,445,684 | |||||||||
| Carey Ng | 35,840,860 | 19,921 | 6,445,683 | |||||||||
| Jane Buchan | 35,731,346 | 129,434 | 6,445,684 | |||||||||
| Yekaterina Chudnovsky | 35,749,420 | 111,360 | 6,445,684 | |||||||||
| Nancy Chang | 35,744,455 | 116,325 | 6,445,684 | |||||||||
| 2. |
Proposal No. 2 - Ratification of Auditors Proposal The stockholders ratified the appointment of Crowe LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. The results of the voting for this proposal were as follows: |
| For | Against | Abstentions | Broker Non-Votes | |||||||||
| 42,276,496 | 11,526 | 18,442 | - | |||||||||